Your browser doesn't support javascript.
loading
Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.
D'Onofrio, Gianluca; Accogli, Andrea; Severino, Mariasavina; Caliskan, Haluk; Kokotovic, Tomislav; Blazekovic, Antonela; Jercic, Kristina Gotovac; Markovic, Silvana; Zigman, Tamara; Goran, Krnjak; Barisic, Nina; Duranovic, Vlasta; Ban, Ana; Borovecki, Fran; Ramadza, Danijela Petkovic; Baric, Ivo; Fazeli, Walid; Herkenrath, Peter; Marini, Carla; Vittorini, Roberta; Gowda, Vykuntaraju; Bouman, Arjan; Rocca, Clarissa; Alkhawaja, Issam Azmi; Murtaza, Bibi Nazia; Rehman, Malik Mujaddad Ur; Al Alam, Chadi; Nader, Gisele; Mancardi, Maria Margherita; Giacomini, Thea; Srivastava, Siddharth; Alvi, Javeria Raza; Tomoum, Hoda; Matricardi, Sara; Iacomino, Michele; Riva, Antonella; Scala, Marcello; Madia, Francesca; Pistorio, Angela; Salpietro, Vincenzo; Minetti, Carlo; Rivière, Jean-Baptiste; Srour, Myriam; Efthymiou, Stephanie; Maroofian, Reza; Houlden, Henry; Vernes, Sonja Catherine; Zara, Federico; Striano, Pasquale; Nagy, Vanja.
Afiliação
  • D'Onofrio G; Department of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Via Gerolamo Gaslini 5, 16147, Genoa, Italy.
  • Accogli A; Division of Medical Genetics, Department of Specialized Medicine, Montreal Children's Hospital, McGill University Health Centre (MUHC), Montreal, Canada.
  • Severino M; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Caliskan H; Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Kokotovic T; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
  • Blazekovic A; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
  • Jercic KG; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Markovic S; Department for Functional Genomics, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb University Hospital Center, Zagreb, Croatia.
  • Zigman T; Department for Functional Genomics, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb University Hospital Center, Zagreb, Croatia.
  • Goran K; Department of Neurology, University Hospital Center Zagreb, University of Zagreb School of Medicine, 10000, Zagreb, Croatia.
  • Barisic N; Department of Pediatrics, General Hospital dr. Tomislav Bardek Koprivnica, Koprivnica, Croatia.
  • Duranovic V; Department of Paediatrics, University Hospital Center Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia.
  • Ban A; Department of Pediatrics, Varazdin General Hospital, Varazdin, Croatia.
  • Borovecki F; Department of Paediatrics, University Hospital Center Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia.
  • Ramadza DP; Division of Neuropediatrics, Department of Pediatrics, Children's Hospital Zagre, Zagreb, Croatia.
  • Baric I; Division of Neuropediatrics, Department of Pediatrics, Children's Hospital Zagre, Zagreb, Croatia.
  • Fazeli W; Department for Functional Genomics, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Zagreb University Hospital Center, Zagreb, Croatia.
  • Herkenrath P; Department of Neurology, University Hospital Center Zagreb, University of Zagreb School of Medicine, 10000, Zagreb, Croatia.
  • Marini C; Department of Paediatrics, University Hospital Center Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia.
  • Vittorini R; Department of Paediatrics, University Hospital Center Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia.
  • Gowda V; Department of Pediatric Neurology, University Hospital Bonn, Bonn, Germany.
  • Bouman A; Department of Pediatric Neurology, University Hospital Bonn, Bonn, Germany.
  • Rocca C; Child Neurology and Psychiatry Unit Children's Hospital "G. Salesi" Azienda Ospedaliero-Universitaria delle Marche Ancona, Ancona, Italy.
  • Alkhawaja IA; Department of Pediatrics, Regina Margherita Children's Hospital, Turin, Italy.
  • Murtaza BN; Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, India.
  • Rehman MMU; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Al Alam C; Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
  • Nader G; Pediatric Neurology Unit, Pediatric Department, Albashir Hospital, Amman, Jordan.
  • Mancardi MM; Department of Zoology, Abbottabad University of Science and Technology, Abbottabad, Pakistan.
  • Giacomini T; Department of Microbiology, Abbottabad University of Science and Technology KP, Abbottabad, Pakistan.
  • Srivastava S; Division of Pediatric Neurology, Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon.
  • Alvi JR; Division of Pediatric Neurology, Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon.
  • Tomoum H; Unit of Child Neuropsychiatry, Department of Clinical and Surgical Neuroscience and Rehabilitation, Epilepsy Center, EPICARE Reference Network, IRCCS Giannina Gaslini, Genoa, Italy.
  • Matricardi S; Unit of Child Neuropsychiatry, Department of Clinical and Surgical Neuroscience and Rehabilitation, Epilepsy Center, EPICARE Reference Network, IRCCS Giannina Gaslini, Genoa, Italy.
  • Iacomino M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Riva A; Department of Pediatric Neurology, Institute of Child Health, Children's Hospital Lahore, Lahore, Pakistan.
  • Scala M; Department of Pediatrics, Ain Shams University, Cairo, Egypt.
  • Madia F; Department of Pediatrics, University of Chieti, Chieti, Italy.
  • Pistorio A; Unit of Medical Genetics-IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Salpietro V; Department of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Via Gerolamo Gaslini 5, 16147, Genoa, Italy.
  • Minetti C; Department of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Via Gerolamo Gaslini 5, 16147, Genoa, Italy.
  • Rivière JB; Unit of Medical Genetics-IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Srour M; Epidemiology and Biostatistics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Efthymiou S; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Maroofian R; Department of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Via Gerolamo Gaslini 5, 16147, Genoa, Italy.
  • Houlden H; Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, H3A 1B1, Canada.
  • Vernes SC; Bioinformatics Platform, Research Institute of the McGill University Health Centre, Montréal, QC, H4A 3J1, Canada.
  • Zara F; Research Institute, McGill University Health Centre, Montreal, QC, Canada.
  • Striano P; Division of Pediatric Neurology, Department of Pediatrics, McGill University, Montreal, QC, Canada.
  • Nagy V; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Hum Genet ; 142(7): 909-925, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37183190
ABSTRACT
Contactin-associated protein-like 2 (CNTNAP2) gene encodes for CASPR2, a presynaptic type 1 transmembrane protein, involved in cell-cell adhesion and synaptic interactions. Biallelic CNTNAP2 loss has been associated with "Pitt-Hopkins-like syndrome-1" (MIM#610042), while the pathogenic role of heterozygous variants remains controversial. We report 22 novel patients harboring mono- (n = 2) and bi-allelic (n = 20) CNTNAP2 variants and carried out a literature review to characterize the genotype-phenotype correlation. Patients (MF 148) were aged between 3 and 19 years and affected by global developmental delay (GDD) (n = 21), moderate to profound intellectual disability (n = 17) and epilepsy (n = 21). Seizures mainly started in the first two years of life (median 22.5 months). Antiseizure medications were successful in controlling the seizures in about two-thirds of the patients. Autism spectrum disorder (ASD) and/or other neuropsychiatric comorbidities were present in nine patients (40.9%). Nonspecific midline brain anomalies were noted in most patients while focal signal abnormalities in the temporal lobes were noted in three subjects. Genotype-phenotype correlation was performed by also including 50 previously published patients (15 mono- and 35 bi-allelic variants). Overall, GDD (p < 0.0001), epilepsy (p < 0.0001), hyporeflexia (p = 0.012), ASD (p = 0.009), language impairment (p = 0.020) and severe cognitive impairment (p = 0.031) were significantly associated with the presence of biallelic versus monoallelic variants. We have defined the main features associated with biallelic CNTNAP2 variants, as severe cognitive impairment, epilepsy and behavioral abnormalities. We propose CASPR2-deficiency neurodevelopmental disorder as an exclusively recessive disease while the contribution of heterozygous variants is less likely to follow an autosomal dominant inheritance pattern.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / Transtorno do Espectro Autista Tipo de estudo: Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Hum Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / Transtorno do Espectro Autista Tipo de estudo: Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Hum Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália